CELL — Cellularline SpA Cashflow Statement
0.000.00%
- €47.18m
- €54.65m
- €156.64m
Annual cashflow statement for Cellularline SpA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -3.85 | -75.2 | 3.6 | 5.65 | -36.3 |
| Depreciation | |||||
| Non-Cash Items | -1.57 | -1.35 | -3.14 | -0.607 | -1.75 |
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 5.5 | -6.67 | -0.814 | 2.76 | 1.58 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Change in Other Liabilities | |||||
| Net Change in Other Assets & Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 19.1 | 4.89 | 13 | 21.5 | 19.4 |
| Capital Expenditures | -5 | -4.61 | -4.89 | -5.31 | -5.65 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -2.37 | -0.786 | -2.55 | — | — |
| Acquisition of Business | |||||
| Cash from Investing Activities | -7.36 | -5.39 | -7.45 | -5.31 | -5.65 |
| Financing Cash Flow Items | -3.3 | -1.32 | -0.837 | -4.95 | -5.49 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | -12.9 | 1.48 | -2.56 | -9.66 | -10.9 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -0.491 | 1.78 | 4.13 | 6.71 | 2.82 |